Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis

Clinical and Vaccine Immunology

Volumn 22, Issue 4, 2015, Pages 398-403

  Chapey, Emmanuelle ^a   Meroni, Valeria ^b   Kieffer, François ^c   Bollani, Lina ^d   Ecochard, René ^a,e,f,g   Garcia, Patricia ^h   Wallon, Martine ^a,i   Peyron, François ^a,i  

^a UNIVERSITÉ LYON 1   (France)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d UNIVERSITY OF PAVIA   (Italy)

^e HOSPICES CIVILS DE LYON   (France)

^f UNIVERSITÉ DE LYON   (France)

^g LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^h HÔPITAL DE LA CONCEPTION   (France)

ⁱ CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; ANALYTICAL PARAMETERS; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONGENITAL TOXOPLASMOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FEMALE; FOLLOW UP; GINGIVA; HUMAN; IMMUNOGLOBULIN ORAL FLUID LEVEL; INFANT; LABORATORY DEVICE; MICROSPONGE; OPTICAL DENSITY; PATIENT MONITORING; PREGNANCY; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; TOXOPLASMOSIS; BODY FLUID; EVALUATION STUDY; IMMUNOLOGY; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; MOUTH; NEWBORN; PRESCHOOL CHILD; PROCEDURES; PROSPECTIVE STUDY; SERUM; TOXOPLASMOSIS, CONGENITAL; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; BODY FLUIDS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOUTH; PREGNANCY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SERUM; SPECIMEN HANDLING; TOXOPLASMOSIS, CONGENITAL; YOUNG ADULT;

EID: 84925456814     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00552-14     Document Type: Article

References (24)

1. Montoya JG, Liesenfeld O. 2004. Toxoplasmosis. Lancet 363:1965-1976. http://dx.doi.org/10.1016/S0140-6736(04)16412-X.
2. Wallon M, Garweg JG, Abrahamowicz M, Cornu C, Vinault S, Quantin C, Bonithon-Kopp C, Picot S, Peyron F, Binquet C. 2014. Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence. Pediatrics 133:e601-e608. http://dx.doi.org/10.1542/peds.2013-2153.
3. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E. 1996. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis 15:799-805. http://dx.doi.org/10.1007/BF01701522.
4. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353: 1829-1833. http://dx.doi.org/10.1016/S0140-6736(98)08220-8.
5. Brandtzaeg P. 2007. Do salivary antibodies reliably reflect both mucosal and systemic immunity? Ann N Y Acad Sci 1098:288-311. http://dx.doi.org/10.1196/annals.1384.012.
6. Miller SM. 1994. Saliva testing - a nontraditional diagnostic tool. Clin Lab Sci 7:39-44.
7. Pavie J, Rachline A, Loze B, Niedbalski L, Delaugerre C, Laforgerie E, Plantier JC, Rozenbaum W, Chevret S, Molina JM, Simon F. 2010. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One 5:e11581. http://dx.doi.org/10.1371/journal.pone.0011581.
8. Oba IT, Spina AM, Saraceni CP, Lemos MF, Senhoras R, Moreira RC, Granato CF. 2000. Detection of hepatitis A antibodies by ELISA using saliva as clinical samples. Rev Inst Med Trop São Paulo 42:197-200. http://dx.doi.org/10.1590/S0036-46652000000400004.
9. Yap G, Sil BK, Ng LC. 2011. Use of saliva for early dengue diagnosis. PLoS Negl Trop Dis 5:e1046. http://dx.doi.org/10.1371/journal.pntd.0001046.
10. Luzza F, Oderda G, Maletta M, Imeneo M, Mesuraca L, Chioboli E, Lerro P, Guandalini S, Pallone F. 1997. Salivary immunoglobulin G assay to diagnose Helicobacter pylori infection in children. J Clin Microbiol 35: 3358-3360.
11. Estévez PT, Satoguina J, Nwakanma DC, West S, Conway DJ, Drakeley CJ. 2011. Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum. Malar J 10:104. http://dx.doi.org/10.1186/1475-2875-10-104.
12. Hutse V, Verhaegen E, De Cock L, Quoilin S, Vandenberghe H, Horsmans Y, Michielsen P, Van Damme P, Van Vlierberghe H, Claeys F, Vranckx R, Van Oyen H. 2005. Oral fluid as a medium for the detection of hepatitis B surface antigen. J Med Virol 77:53-56. http://dx.doi.org/10.1002/jmv.20413.
13. Fung AO, Damoiseaux R, Grundeen S, Panes JL, Horton DH, Judy JW, Moore TB. 2012. Quantitative detection of PfHRP2 in saliva of malaria patients in the Philippines. Malar J 11:175. http://dx.doi.org/10.1186/1475-2875-11-175.
14. Ng SM, Drury JA, Turner MA, Didi M, Victor S, Newland P, Weindling AM. 2013. A novel method of collection of saliva for estimation of steroid levels in extremely premature infants. Acta Paediatr 102:356-359. http://dx.doi.org/10.1111/apa.12146.
15. Chahed Bel-Ochi N, Bouratbine A, Mousli M. 2013. Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and saliva. Clin Vaccine Immunol 20:468-473. http://dx.doi.org/10.1128/CVI.00512-12.
16. Stroehle A, Schmid K, Heinzer I, Naguleswaran A, Hemphill A. 2005. Performance of a Western immunoblot assay to detect specific anti-Toxoplasma gondii IgG antibodies in human saliva. J Parasitol 91:561-563. http://dx.doi.org/10.1645/GE-423R.
17. Hajeer AH, Balfour AH, Mostratos A, Crosse B. 1994. Toxoplasma gondii: detection of antibodies in human saliva and serum. Parasite Immunol 16:43-50.
18. Loyola AM, Durighetto AF, Silva DA, Mineo JR. 1997. Anti-Toxoplasma gondii immunoglobulins A and G in human saliva and serum. J Oral Pathol Med 26:187-191.
19. Tapia MD, Pasetti MF, Cuberos L, Sow SO, Doumbia MN, Bagayogo M, Kotloff KL, Levine MM. 2006. Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys. Pediatr Infect Dis J 25:819-825. http://dx.doi.org/10.1097/01.inf.0000232629.72160.bb.
20. Vyse AJ, Cohen BJ, Ramsay ME. 2001. A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health 115:201-207. http://dx.doi.org/10.1038/sj/ph/1900751.
21. Jaisson-Hot I, Wallon M, al Kurdi M, Thulliez P, Kahi S, Cozon G, Peyron F. 2001. Congenital toxoplasmosis. Transitory negative serology. Presse Med 30:1001-1004. (In French.)
22. Wallon M, Cozon G, Ecochard R, Lewin P, Peyron F. 2001. Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children. Eur J Pediatr 160:534-540. http://dx.doi.org/10.1007/s004310100805.
23. Yoshizawa JM, Schafer CA, Schafer JJ, Farrell JJ, Paster BJ, Wong DTW. 2013. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev 26:781-791. http://dx.doi.org/10.1128/CMR.00021-13.
24. Jafa K, Patel P, Mackellar DA, Sullivan PS, Delaney KP, Sides TL, Newman AP, Paul SM, Cadoff EM, Martin EG, Keenan PA, Branson BM, OraQuick Study Group. 2007. Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS One 2:e185. http://dx.doi.org/10.1371/journal.pone.0000185.